Origin and evolution of SARS-CoV-2

被引:0
|
作者
Isabel Pagani
Silvia Ghezzi
Simone Alberti
Guido Poli
Elisa Vicenzi
机构
[1] San Raffaele Scientific Institute,Viral Pathogenesis and Biosafety Unit, Division of Immunology, Transplantation, and Infectious Diseases
[2] San Raffaele Scientific Institute,Human Immuno
[3] Vita-Salute San Raffaele University School of Medicine,Virology (H.I.V.) Unit, Division of Immunology, Transplantation, and Infectious Diseases
关键词
D O I
暂无
中图分类号
学科分类号
摘要
SARS-CoV-2 is a novel coronavirus that emerged in China at the end of 2019 causing the severe disease known as coronavirus disease 2019 (COVID-19). SARS-CoV-2, as to the previously highly pathogenic human coronaviruses named SARS-CoV, the etiological agent of severe acute respiratory syndrome (SARS), has a zoonotic origin, although SARS-CoV-2 precise chain of animal-to-human transmission remains undefined. Unlike the 2002–2003 pandemic caused by SARS-CoV whose extinction from the human population was achieved in eight months, SARS-CoV-2 has been spreading globally in an immunologically naïve population in an unprecedented manner. The efficient infection and replication of SARS-CoV-2 has resulted in the emergence of viral variants that have become predominant posing concerns about their containment as they are more infectious with variable pathogenicity in respect to the original virus. Although vaccine availability is limiting severe disease and death caused by SARS-CoV-2 infection, its extinction is far to be close and predictable. In this regard, the emersion of the Omicron viral variant in November 2021 was characterized by humoral immune escape and it has reinforced the importance of the global monitoring of SARS-CoV-2 evolution. Given the importance of the SARS-CoV-2 zoonotic origin, it will also be crucial to monitor the animal-human interface to be better prepared to cope with future infections of pandemic potential.
引用
收藏
相关论文
共 50 条
  • [21] Tracking SARS-CoV-2 evolution
    Hahn, A. M.
    Chaguza, C.
    Breban, M. L.
    Chen, N.
    Koch, T. R.
    Pham, K.
    Vogels, C. B. F.
    Grubaugh, N. D.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 60 - 60
  • [22] Climate change and the origin of SARS-CoV-2
    Yam, Esabelle Lo Yan
    JOURNAL OF TRAVEL MEDICINE, 2020, 27 (08)
  • [23] Scientific evidence on the origin of SARS-CoV-2
    Domingo, Jose L.
    ENVIRONMENTAL RESEARCH, 2021, 201
  • [24] Origin and Reversion of Omicron Core Mutations in the Evolution of SARS-CoV-2 Genomes
    Zhao, Xinwei
    Qin, Luyao
    Ding, Xiao
    Zhang, Yudi
    Niu, Xuefeng
    Gao, Feng
    Jiang, Taijiao
    Chen, Ling
    VIRUSES-BASEL, 2023, 15 (01):
  • [25] Scientific evidence on the origin of SARS-CoV-2
    Nunez-Delgado, Avelino
    Ahmed, Warish
    Romande, Jesus L.
    Dhama, Kuldeep
    Domingo, Jose L.
    ENVIRONMENTAL RESEARCH, 2023, 216
  • [26] The origin of SARS-CoV-2 variants of concern
    Burki, Talha
    LANCET INFECTIOUS DISEASES, 2022, 22 (02): : 174 - 175
  • [27] Investigations into the origin of SARS-CoV-2: an update
    Mitra, Anirban
    CURRENT SCIENCE, 2021, 121 (01): : 77 - 84
  • [28] The Importance of Research on the Origin of SARS-CoV-2
    Lundstrom, Kenneth
    Seyran, Murat
    Pizzol, Damiano
    Adadi, Parise
    Mohamed Abd El-Aziz, Tarek
    Hassan, Sk. Sarif
    Soares, Antonio
    Kandimalla, Ramesh
    Tambuwala, Murtaza M.
    Aljabali, Alaa A. A.
    Kumar Azad, Gajendra
    Pal Choudhury, Pabitra
    Uversky, Vladimir N.
    Sherchan, Samendra P.
    Uhal, Bruce D.
    Rezaei, Nima
    Brufsky, Adam M.
    VIRUSES-BASEL, 2020, 12 (11):
  • [29] The Origin of Sars-CoV-2: Why It Matters
    Vineis, Paolo
    Salmaso, Stefania
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [30] Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
    Shahrajabian, Mohamad Hesam
    Sun, Wenli
    Cheng, Qi
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (01) : 62 - 83